GlassScriptPhysician profile
Jeff J Pan
NPI 1437261138
$984.83
in general payments reported to CMS, 2019-2025
9 companies · $65.34 in 2025
The $65.34 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $21.68 · 2021: $18.47 · 2023: $16.01 · 2024: $50.83 · 2025: $65.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $237.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $206.34 | 2019 | |
| Astellas Pharma US INC | $185.38 | 2019-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $157.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $75.00 | 2019 | |
| Pfizer INC. | $69.65 | 2019-2024 | |
| Procept Biorobotics Corporation | $21.98 | 2024 | Aquabeam System |
| Urogen Pharma, INC. | $18.47 | 2021 | |
| Metuchen Pharmaceuticals | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.